A series of experiments were undertaken to examine the effects of interferon (IFN)-τ on regulation of prostaglandin H synthase (PGHS)-2 mRNA in bovine endometrial (BEND) cells as a means to elucidate the actions of IFN-τ to maintain pregnancy. The objective was to determine if IFN-τ mediates posttranscriptional regulation of PGHS-2 mRNA. Cells were treated with phorbol 12,13-dibutyrate (PdBu) for 3 h to induce PGHS-2 mRNA expression. Actinomycin D (0 or 1 μg/ml) or the p38 mitogen-activated protein kinase (MAPK) inhibitor, SB203580 (1 μM), were added at 3 h, followed by addition of IFN-τ (0 or 50 ng/ml) at 3.5 h and extraction of RNA at 4.5 h. The concentrations of PGHS-2 mRNA were stable between 3 and 4.5 h regardless of actinomycin D. Simultaneous treatment of PdBu-treated cells with actinomycin D and SB203580 (1 μM) decreased PGHS-2 mRNA. Addition of IFN-τ (50 ng/ml) reduced PGHS-2 mRNA, which was not observed when actinomycin D was present. Concurrent treatments of cells with SB203580 and IFN-τ (5 ng/ml) decreased concentrations of PGHS-2 mRNA in an additive manner. Although IFN-τ reduced PGHS-2 mRNA concentrations, phosphorylation of p38 MAPK was induced by IFN-τ, PdBu, and PdBu combined with IFN-τ after 10 min of treatment. Both the p38 MAPK inhibitor and IFN-τ decreased prostaglandin F2α secretion, and decreases were additive when the two were given together. In summary, activation of p38 MAPK by PdBu is required for continued presence of PGHS-2 mRNA and secretion of prostaglandin F2α in BEND cells. Interferon-τ mediates a transcription-dependent mechanism, which induces degradation of PGHS-2 mRNA. However, the consequences of an IFN-τ-induced activation of p38 MAPK warrant further investigation, because inhibition of p38 MAPK caused a degradation of PGHS-2 mRNA.
Translator Disclaimer
ACCESS THE FULL ARTICLE
It is not available for individual sale.
This article is only available to subscribers.
It is not available for individual sale.
It is not available for individual sale.